-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Neutral on Edwards Lifesciences, Raises Price Target to $90

Benzinga·10/31/2025 18:31:08
Listen to the news
JP Morgan analyst Robbie Marcus maintains Edwards Lifesciences (NYSE:EW) with a Neutral and raises the price target from $85 to $90.